Class IIOngoingD-0538-2023
Drug recall · April 26, 2023
C-Semaglutide 5mg/mL injection recall
Why: Lack of assurance of sterility.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
C-Semaglutide 5mg/mL injection, 0.5mL vials, Rx only, Vital Care Compounder 115 South 40th Ave, Suite A Hattiesburg, MS 39402
- Lots / codes
Lot #: 73810, Exp. Date 5/1/2023
- Quantity
- 45 vials
- Company
- Pharmacy Plus, Inc. dba Vital Care Compounder, Hattiesburg, MS
- Distribution
- MS only
- Initiated
- April 13, 2023 · Voluntary: Firm initiated
- Classified
- April 19, 2023
- Reported
- April 26, 2023
- How notified
- Telephone
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.